Some of the known mechanisms include biochemical processes related to the light–dark cycle processed by the retinohypothalamic tract through glutamate, PACAP-38 [93] and its subsequent secretion of melatonin [94], with levels being lower in CH patients [95]. This evidence concerns the gene ADCYAP1 and cyclic hematopoiesis.